To help ease COVID concerns, American College of Cardiology will offer continuous screening for conference attendees

After COVID-19 forced the American College of Cardiology (ACC) to cancel its annual meeting in 2020, the organization is looking ahead to ensure attendees feel safe and comfortable during its 2021 annual meeting, ACC.21, in Atlanta. 

The conference, scheduled for May 15-17, is expected to include cardiologists and other industry insiders from all over the world. On Monday, Jan. 11, the ACC announced that attendees will be able to monitor their vital signs with the BioButton COVID-19 Screening Solution, a wearable device developed by BioIntelliSense. This comes after the ACC and BioIntelliSense agreed to launch a new strategic partnership focused on improving patient care.

“The ACC—and the cardiovascular community as a whole—has a long history of advancing innovative solutions to transform cardiovascular care and patient outcomes,” ACC President Athena Poppas, MD, said in a prepared statement. “We are excited by the opportunity to partner with BioIntelliSense and be on the cutting edge of an innovative technology with real-time health data and feedback.”

“We are proud to form a strategic collaboration with the ACC to advance virtual care and remote patient monitoring programs that can transform cardiac care,” added James Mault, MD, CEO of BioIntelliSense. “Together with the ACC, we can provide the cardiology community with medical-grade monitoring devices, clinically validated algorithms and remote patient monitoring education that will have a profound impact on routine patient care globally.”

Back in September, ACC.21 was pushed back from March 2021 to its currently scheduled dates.

“The health, safety and well-being of our members, staff, exhibitors, faculty, patients and other stakeholders remain of paramount importance,” the ACC said at the time in a statement. “With continued uncertainty surrounding the COVID-19 pandemic and travel advisories and restrictions still in place in the U.S. and globally, the college hopes the new dates will allow more people to attend ACC.21 in person.”

More information related to ACC.21 is available here. An online version of the conference, ACC.21 Virtual, will allow interested parties to participate from the comfort of home.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup